Background: Obesity is associated with the development and progression of c hronic kidney disease. Emerging evidence suggests that glucagon-like p eptide-1 receptor agonist could reduce renal damage and albuminuria. Sirtuin 1 (S IRT1) was considered as a crucial regulator in metabolism-related kidney disease. https://trendingcustomes.shop/product-category/acrylic-record-plaque/